Geovax Labs (GOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,562 | 769 | 6,453 | 12,687 | 17,789 |
| Receivables | 301 | N/A | N/A | N/A | N/A |
| TOTAL | $3,844 | $2,862 | $7,886 | $14,800 | $19,827 |
| Non-Current Assets | |||||
| PPE Net | 171 | 190 | 210 | 213 | 224 |
| Other Non-Current Assets | 81 | 306 | 1,188 | 1,188 | 1,198 |
| TOTAL | $252 | $496 | $1,398 | $1,401 | $1,422 |
| Total Assets | $4,095 | $3,358 | $9,283 | $16,201 | $21,249 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,984 | 1,884 | 2,803 | 4,213 | 871 |
| Accrued Expenses | 2,278 | 1,420 | 717 | 2,868 | 3,214 |
| TOTAL | $6,404 | $3,304 | $3,520 | $7,082 | $4,086 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,404 | $3,304 | $3,520 | $7,082 | $4,086 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,264 | 2,308 | 2,172 | 1,781 | 1,764 |
| Common Shares | 4 | 2 | 2 | 27 | 26 |
| Retained earnings | -115,278 | -110,214 | -104,364 | -96,771 | -88,363 |
| TOTAL | $-2,309 | $54 | $5,763 | $9,119 | $17,164 |
| Total Liabilities And Equity | $4,095 | $3,358 | $9,283 | $16,201 | $21,249 |